University Of Cincinnati College Of Medicine
- Address
- 260 Stetson Street
Sponsor Overview
Specializations
Stroke and Acute Haemorrhagic Neurology
Clinical research is centered on acute haemorrhagic stroke, with a focus on intracerebral hemorrhage and emergency treatment for spontaneous bleeding in the brain.
- Acute spontaneous intracerebral hemorrhage
- Functional recovery after stroke
- Disability outcomes measured by the modified Rankin Scale
The research activity is directed toward early intervention in patients with life-threatening brain hemorrhage, with attention to neurological recovery and dependence in daily functioning.
Hemostatic and Coagulation Therapy
Therapeutic interest includes recombinant Factor VIIa as a treatment approach for controlling bleeding within the brain and limiting hematoma expansion.
- Recombinant Factor VIIa
- Coagulation factor treatment
- Bleeding control in acute brain injury
This area reflects a strong focus on hemostatic therapy for urgent neurological conditions where rapid stabilization of hemorrhage is clinically important.
Emergency Neurologic Care
Research activity emphasizes treatment delivered in the earliest window after symptom onset, supporting urgent care pathways for patients with sudden brain hemorrhage.
- Time-sensitive intervention
- Emergency stroke management
- Early treatment of intracranial bleeding
The clinical focus is on patients presenting shortly after onset, where rapid therapeutic action may influence neurological outcome.
Neuroimaging and Patient Stratification
Interest extends to baseline imaging features used in acute stroke care, including CTA findings such as the spot sign for identifying patients with active bleeding risk.
- Computed tomography angiography (CTA)
- Spot sign identification
- Risk stratification in hemorrhagic stroke
These imaging-related elements support clinical decision-making in hemorrhagic stroke and help define the most relevant patient groups for treatment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Recombinant Coagulation Factor VIIa (Eptacog Alfa, Activated) for Acute Hemorrhagic Stroke in Early Administration: A Randomized Controlled Trial |  Germany Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 17 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
17 centres- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Avenida Ramon Y Cajal 3, 47003 Valladolid
- Address
- Carrer De San Quinti 89, 08041 Barcelona
- Address
- Avinguda De L'alcalde Rovira Roure 80, 25196 Lleida
- Address
- Avinguda De Franca S/n, 17007 Girona
Want to get in touch with this sponsor?
Send a question and we'll pass it on to University Of Cincinnati College Of Medicine.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.